In this meta-analysis, researchers evaluated the use and/or prolongation of ADT in men with non-metastatic prostate cancer undergoing definitive radiotherapy. For men with prostate cancer treated with ...
Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel treatments for recurrent and metastatic cancer, today announced that it has submitted ...
Learn about prostate cancer symptoms, diagnosis, staging and the latest treatments including robotic surgery, SBRT, radioligand therapy and targeted drugs.
Dilbert creator and outspoken Trump supporter Scott Adams posted a video from the hospital on Wednesday instead of his daily ...
Not only is he positive, but he’s the most competitive person I know,” Kristi said. “So he is going to fight like heck, and I ...
From Trial Diversity to Telehealth: Advancing Equity and Access in Rural and Underserved Cancer Care
There was also a shared emphasis on expanding and integrating clinical trials through broadening trial eligibility criteria ...
Five LMU researchers have been awarded Consolidator Grants by the European Research Council. Their projects deal with climate change, strokes, ...
Understand the rising rates of incurable prostate cancer in Canada and the importance of self-advocacy for testing.
My best advice for anyone recently diagnosed with MBC is to keep a notebook and take someone with you to every appointment.
News-Medical.Net on MSN
Addition of tucatinib to the standard of care delays disease progression in HER2-positive metastatic breast cancer
Adding tucatinib (Tukysa) to first-line maintenance therapy with trastuzumab (Herceptin) and pertuzumab (Perjeta) delayed ...
Dan, diagnosed with stage 4 pancreatic cancer, shares his journey to remission and insights on clinical trials and patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results